364 related articles for article (PubMed ID: 15210108)
1. Yin Yang 1 is a negative regulator of p53.
Sui G; Affar el B; Shi Y; Brignone C; Wall NR; Yin P; Donohoe M; Luke MP; Calvo D; Grossman SR; Shi Y
Cell; 2004 Jun; 117(7):859-72. PubMed ID: 15210108
[TBL] [Abstract][Full Text] [Related]
2. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
Grönroos E; Terentiev AA; Punga T; Ericsson J
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
[TBL] [Abstract][Full Text] [Related]
3. p53 promotes its own polyubiquitination by enhancing the HDM2 and HDMX interaction.
Medina-Medina I; Martínez-Sánchez M; Hernández-Monge J; Fahraeus R; Muller P; Olivares-Illana V
Protein Sci; 2018 May; 27(5):976-986. PubMed ID: 29524278
[TBL] [Abstract][Full Text] [Related]
4. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y
Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427
[TBL] [Abstract][Full Text] [Related]
6. A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage.
Yan J; Menendez D; Yang XP; Resnick MA; Jetten AM
J Biol Chem; 2009 Jul; 284(29):19280-9. PubMed ID: 19433585
[TBL] [Abstract][Full Text] [Related]
7. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
9. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.
Phillips A; Teunisse A; Lam S; Lodder K; Darley M; Emaduddin M; Wolf A; Richter J; de Lange J; Verlaan-de Vries M; Lenos K; Böhnke A; Bartel F; Blaydes JP; Jochemsen AG
J Biol Chem; 2010 Sep; 285(38):29111-27. PubMed ID: 20659896
[TBL] [Abstract][Full Text] [Related]
10. HDM2 negatively affects the Chk2-mediated phosphorylation of p53.
Bjørling-Poulsen M; Meek D; Issinger OG
FEBS Lett; 2005 May; 579(12):2604-8. PubMed ID: 15862297
[TBL] [Abstract][Full Text] [Related]
11. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
12. HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma.
Shi Y; Takenobu H; Kurata K; Yamaguchi Y; Yanagisawa R; Ohira M; Koike K; Nakagawara A; Jiang LL; Kamijo T
Eur J Cancer; 2010 Aug; 46(12):2324-34. PubMed ID: 20591651
[TBL] [Abstract][Full Text] [Related]
13. Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.
Ding Y; Lee JF; Lu H; Lee MH; Yan DH
Mol Cell Biol; 2006 Mar; 26(5):1979-96. PubMed ID: 16479015
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
[TBL] [Abstract][Full Text] [Related]
16. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.
Calabrò V; Mansueto G; Parisi T; Vivo M; Calogero RA; La Mantia G
J Biol Chem; 2002 Jan; 277(4):2674-81. PubMed ID: 11714701
[TBL] [Abstract][Full Text] [Related]
17. A stapled p53 helix overcomes HDMX-mediated suppression of p53.
Bernal F; Wade M; Godes M; Davis TN; Whitehead DG; Kung AL; Wahl GM; Walensky LD
Cancer Cell; 2010 Nov; 18(5):411-22. PubMed ID: 21075307
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
19. Akt enhances Mdm2-mediated ubiquitination and degradation of p53.
Ogawara Y; Kishishita S; Obata T; Isazawa Y; Suzuki T; Tanaka K; Masuyama N; Gotoh Y
J Biol Chem; 2002 Jun; 277(24):21843-50. PubMed ID: 11923280
[TBL] [Abstract][Full Text] [Related]
20. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression.
Bárdos JI; Chau NM; Ashcroft M
Mol Cell Biol; 2004 Apr; 24(7):2905-14. PubMed ID: 15024078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
